AbbVie Header AbbVie Header

X

Find the latest Drugs in Development and Pipeline Prospector News of Carbon Health.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Carbon Health
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
San Francisco, CA
Telephone
Telephone
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Details:

Merck has selected Carbon Health to participate in two double-blinded phase III International clinical trials to test the effectiveness of a new COVID-19 antiviral treatment pill, molnupiravir for both treatment and prophylaxis indications.


Lead Product(s): Molnupiravir

Therapeutic Area: Infections and Infectious Diseases Product Name: MK-4482

Highest Development Status: Phase IIIProduct Type: Small molecule

Partner/Sponsor/Collaborator: Merck & Co

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Partnership September 30, 2021

ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY